Visit Radcliffe Cardiology: [ Ссылка ]

AHA 22 - CardioNerds Fellow, Dr Saahil A Jumkhawala (Rutgers New Jersey Medical School, US) is joined by investigator, Prof Hiroyuki Daida (Juntendo Graduate School of Medicine, JP) to discuss the findings of the RESPECT EPA first presented at AHA 2022.

This randomized phase 4 trial looked at Japanese participants to assess whether long-term use of icosapent ethyl 1800 mg daily in addition to statin therapy would be more effective in preventing cardiovascular events in patients with hypercholesterolemia compared to station therapy alone.

Recorded remotely from Tokyo & New Jersey, 2022.

Editor: Mirjam Boros, Jordan Rance
Video Specialist: Oliver Miles
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

свернуть